MDS disease characteristics, not donor source, predict hematopoietic stem cell transplant outcomes

Myelodysplastic syndrome (MDS) is a heterogeneous group of hematological malignancies with considerably variable prognoses and curable only with hematopoietic cell transplantation (HCT). Few studies comparing MDS HCT outcomes between sibling and umbilical cord blood (UCB) donors exist. Using the Uni...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Bone Marrow Transplant
Hoofdauteurs: Pourhassan, H, DeFor, T, Trottier, B, Dolan, M, Brunstein, C, Bejanyan, N, Ustun, C, Warlick, E D
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Nature Publishing Group UK 2016
Onderwerpen:
Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5382091/
https://ncbi.nlm.nih.gov/pubmed/27941767
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bmt.2016.303
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items